Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma (Q50147228)

25 February 2018

http://europepmc.org/abstract/MED/24067719

title

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma (English)

1 reference

25 February 2018

http://europepmc.org/abstract/MED/24067719

author

Michele Maio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Jacopo Pigozzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Michele Del Vecchio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Paola Queirolo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Riccardo Danielli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Vanna Chiarion Sileni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Lorenza Di Guardo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Paolo Marchetti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Michele Guida

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

G Parmiani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

R Ridolfi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

F De Rosa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

V Picasso

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

F De Galitiis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

M Mandalà

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

E Simeone

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

P A Ascierto

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

25 September 2013

1 reference

25 February 2018

http://europepmc.org/abstract/MED/24067719

published in

Annals of Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

2911-2915

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Uveal melanoma: epidemiologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Management of posterior uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Effectiveness of treatments for metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Lack of BRAF mutation in primary uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Mutations in GNA11 in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Locoregional management of hepatic metastasis from primary uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Management of immune-related adverse events and kinetics of response with ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Ipilimumab activity in advanced uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT376

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference